FULLER H B CO 10-Q

ful20220226_10q.htm     Table of Contents   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-Q   (Mark One)   ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 26, 2022   OR   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the transition period from                              to                                  .   Commission file number: 001-09225   H.B. FULLER COMPANY (Exact name of registrant as specified in its charter)   Minnesota 41-0268370 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.)                                                                                 1200 Willow Lake Boulevard , St. Paul , Minnesota 55110-5101 (Address of principal executive offices) (Zip Code)                                                                                                                               Registrant’s telephone number, including area code: ( 651 ) 236-5900   Not Applicable (Former name, former address and former fiscal year, if changed since last report)   Securities registered pursuant to section 12(b) of the Act:     Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $1.00 per share       FUL New York Stock Exchange   Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):                      Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   1 Table of Contents   Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b) of the Exchange Act. Yes ☐ No ☒   APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PROCEEDING FIVE YEARS:   Indicate by check mark whether the registrant has filed all documents and reports required to be filed by section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☐ No ☐   APPLICABLE ONLY TO CORPORATE ISSUERS   The number of shares outstanding of the Registrant’s Common Stock, par value $1.00 per share, was 53,053,268  as of March 18, 2022.   2 Table of Contents       H.B. Fuller Company Quarterly Report on Form 10-Q Table of Contents       Page PART 1. FINANCIAL INFORMATION         ITEM 1. FINANCIAL STATEMENTS (Unaudited) 4         Consolidated Statements of Income for the three months ended February 26, 2022 and February 27, 2021 4         Consolidated Statements of Comprehensive Income for the three months ended February 26, 2022 and February 27, 2021 5         Consolidated Balance Sheets as of February 26, 2022 and November 27, 2021 6         Consolidated Statements of Total Equity for the three months ended February 26, 2022 and February 27, 2021 7         Consolidated Statements of Cash Flows for the three months ended February 26, 2022 and February 27, 2021 8         Notes to Consolidated Financial Statements 9       ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 23       ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 34       ITEM 4. CONTROLS AND PROCEDURES 34       PART II. OTHER INFORMATION 34       ITEM 1. LEGAL PROCEEDINGS 34       ITEM 1A. RISK FACTORS 35       ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 36       ITEM 6. EXHIBITS 37       SIGNATURES 38   3 Table of Contents       PART I. FINANCIAL INFORMATION   Item 1. Financial Statements   H.B. FULLER COMPANY AND SUBSIDIARIES Consolidated Statements of Income (In thousands, except per share amounts) (Unaudited)       Three Months Ended       February 26,     February 27,       2022     2021   Net revenue   $ 856,482     $ 725,904   Cost of sales     ( 643,589 )     ( 533,540 ) Gross profit     212,893       192,364   Selling, general and administrative expenses     ( 155,894 )     ( 144,014 ) Other income, net     6,142       7,869   Interest expense     ( 18,196 )     ( 20,361 ) Interest income     1,940       2,659   Income before income taxes and income from equity method investments     46,885       38,517   Income taxes     ( 10,148 )     ( 10,607 ) Income from equity method investments     1,583       1,896   Net income including non-controlling interest     38,320       29,806   Net income attributable to non-controlling interest     ( 14 )     ( 15 ) Net income attributable to H.B. Fuller   $ 38,306     $ 29,791                     Earnings per share attributable to H.B. Fuller common stockholders:                 Basic   $ 0.72     $ 0.57   Diluted   $ 0.69     $ 0.56                     Weighted-average common shares outstanding:                 Basic     53,353       52,492   Diluted     55,395       53,339                     Dividends declared per common share   $ 0.168     $ 0.163     See accompanying Notes to Unaudited Consolidated Financial Statements.   4 Table of Contents     H.B. FULLER COMPANY AND SUBSIDIARIES Consolidated Statements of Comprehensive Income (In thousands) (Unaudited)       Three Months Ended       February 26,     February 27,       2022     2021   Net income including non-controlling interest   $ 38,320     $ 29,806   Other comprehensive income                 Foreign currency translation     6,530       23,137   Defined benefit pension plans adjustment, net of tax     489       1,375   Interest rate swaps, net of tax     6,231       4,180   Cross-currency swaps, net of tax     ( 2,083 )     ( 1,046 ) Other comprehensive income     11,167       27,646   Comprehensive income     49,487       57,452   Less: Comprehensive income attributable to non-controlling interest     4       5   Comprehensive income attributable to H.B. Fuller   $ 49,483     $ 57,447     See accompanying Notes to Unaudited Consolidated Financial Statements.   5 Table of Contents   H.B. FULLER COMPANY AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except share and per share amounts) (Unaudited)       February 26,     November 27,       2022     2021   Assets                 Current assets:                 Cash and cash equivalents   $ 63,511     $ 61,786   Trade receivables (net of allowances of $10,736 and $9,935 , as of February 26, 2022 and November 27, 2021, respectively)     616,274       614,645   Inventories     547,868       448,404   Other current assets     120,966       96,335   Total current assets     1,348,619       1,221,170                     Property, plant and equipment     1,536,539       1,500,989   Accumulated depreciation     ( 823,744 )     ( 805,622 ) Property, plant and equipment, net     712,795       695,367                     Goodwill     1,425,936       1,298,845   Other intangibles, net     785,389       687,075   Other assets     368,700       372,073   Total assets   $ 4,641,439     $ 4,274,530                     Liabilities, non-controlling interest and total equity                 Current liabilities:                 Notes payable   $ 25,866     $ 24,983   Trade payables     531,428       500,321   Accrued compensation     65,604       109,542   Income taxes payable     20,570       15,943   Other accrued expenses     78,468       86,061   Total current liabilities     721,936       736,850                     Long-term debt     1,888,264       1,591,479   Accrued pension liabilities     71,358       71,651   Other liabilities     314,033       277,190   Total liabilities     2,995,591       2,677,170                     Commitments and contingencies (Note 12)                                       Equity:                 H.B. Fuller stockholders' equity:                 Preferred stock ( no shares outstanding) shares authorized – 10,045,900     -       -   Common stock, par value $1.00 per share, shares authorized – 160,000,000 , shares outstanding – 53,041,801 and 52,777,753 as of February 26, 2022 and November 27, 2021, respectively     53,042       52,778   Additional paid-in capital     221,338       213,637   Retained earnings     1,629,943       1,600,601   Accumulated other comprehensive loss     ( 259,070 )     ( 270,247 ) Total H.B. Fuller stockholders' equity     1,645,253       1,596,769   Non-controlling interest     595       591   Total equity     1,645,848       1,597,360   Total liabilities, non-controlling interest and total equity   $ 4,641,439     $ 4,274,530      See accompanying Notes to Unaudited Consolidated Financial Statements.   6 Table of Contents   H.B. FULLER COMPANY AND SUBSIDIARIES Consolidated Statements of Total Equity (In thousands) (Unaudited)       H.B. Fuller Company Shareholders                                               Accumulated                               Additional             Other                       Common     Paid-in     Retained     Comprehensive     Non-Controlling               Stock     Capital     Earnings     Income (Loss)     Interest     Total                                                     Balance at November 27, 2021   $ 52,778     $ 213,637     $ 1,600,601     $ ( 270,247 )   $ 591     $ 1,597,360   Comprehensive income     -       -       38,306       11,177       4       49,487   Dividends     -       -       ( 8,964 )     -       -       ( 8,964 ) Stock option exercises     126       5,628       -       -       -       5,754   Share-based compensation plans and other, net     187       5,601       -       -       -       5,788   Repurchases of common stock     ( 49 )     ( 3,528 )     -       -       -       ( 3,577 ) Balance at February 26, 2022   $ 53,042     $ 221,338     $ 1,629,943     $ ( 259,070 )   $ 595     $ 1,645,848         H.B. Fuller Company Shareholders                                               Accumulated                               Additional             Other                       Common     Paid-in     Retained     Comprehensive     Non-Controlling               Stock     Capital     Earnings     Income (Loss)     Interest     Total                                                     Balance at November 28, 2020   $ 51,907     $ 157,867     $ 1,474,406     $ ( 302,859 )   $ 541     $ 1,381,862   Comprehensive income     -       -       29,791       27,656       5       57,452   Dividends     -       -       ( 8,542 )     -       -       ( 8,542 ) Stock option exercises     147       6,251       -       -       -       6,398   Share-based compensation plans and other, net     150       7,423       -       -       -       7,573   Repurchases of common stock     ( 49 )     ( 2,531 )     -       -       -       ( 2,580 ) Balance at February 27, 2021   $ 52,155     $ 169,010     $ 1,495,655     $ ( 275,203 )   $ 546     $ 1,442,163     See accompanying Notes to Unaudited Consolidated Financial Statements.    7 Table of Contents     H.B. FULLER COMPANY AND SUBSIDIARIES Consolidated Statements of Cash Flows (In thousands) (Unaudited)       Three Months Ended       February 26, 2022     February 27, 2021   Cash flows from operating activities:                 Net income including non-controlling interest   $ 38,320     $ 29,806   Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:                 Depreciation     18,163       17,833   Amortization     17,792       17,896   Deferred income taxes     ( 6,020 )     ( 2,281 ) Income from equity method investments, net of dividends received     ( 1,583 )     ( 1,896 ) Loss on sale or disposal of assets     ( 13 )     ( 16 ) Share-based compensation     5,091       6,821   Pension and other post-retirement benefit plan activity     ( 5,361 )     ( 7,999 ) Change in assets and liabilities, net of effects of acquisitions:                 Trade receivables, net     13,283       3,318   Inventories     ( 87,419 )     ( 63,598 ) Other assets     ( 3,195 )     ( 1,871 ) Trade payables     46,464       67,373   Accrued compensation     ( 44,066 )     ( 18,146 ) Other accrued expenses     ( 6,839 )     753   Income taxes payable     6,698       882   Other liabilities     ( 8,810 )     ( 17,921 ) Other     ( 178 )     4,895   Net cash (used in) provided by operating activities     ( 17,673 )     35,849                     Cash flows from investing activities:                 Purchased property, plant and equipment     ( 48,883 )     ( 35,283 ) Purchased businesses, net of cash acquired     ( 229,314 )     ( 5,445 ) Proceeds from sale of property, plant and equipment     22       263   Cash received from government grant     3,928       -   Cash payments related to government grant     -       ( 1,526 ) Net cash used in investing activities     ( 274,247 )     ( 41,991 )                   Cash flows from financing activities:                 Proceeds from debt     307,500       -   Repayment of long-term debt     -       ( 11,000 ) Payment of debt issuance costs     ( 400 )     -   Net payments of notes payable     ( 7,604 )     ( 22 ) Dividends paid     ( 8,881 )     ( 8,460 ) Contingent consideration payment     ( 5,000 )     -   Proceeds from stock options exercised     5,754       6,398   Repurchases of common stock     ( 3,577 )     ( 2,580 ) Net cash provided by (used in) financing activities     287,792       ( 15,664 )                   Effect of exchange rate changes on cash and cash equivalents     5,853       2,464   Net change in cash and cash equivalents     1,725       ( 19,342 ) Cash and cash equivalents at beginning of period     61,786       100,534   Cash and cash equivalents at end of period   $ 63,511     $ 81,192     See accompanying Notes to Unaudited Consolidated Financial Statements.   8 Table of Contents   H.B. FULLER COMPANY AND SUBSIDIARIES Notes to Consolidated Financial Statements (Amounts in thousands, except per share amounts) (Unaudited)     Note 1: Basis of Presentation   Overview   The accompanying unaudited interim Consolidated Financial Statements of H.B. Fuller Company and Subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and the instructions to Form 10 -Q and Article 10 of Regulation S- X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, comprehensive income, financial position and cash flows in conformity with U.S. generally accepted accounting principles. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature considered necessary for the fair presentation of the results for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.   The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from these estimates. These unaudited interim Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in our Annual Report on Form 10 -K for the year ended  November 27, 2021 as filed with the Securities and Exchange Commission.   New Accounting Pronouncements   In November 2021, the FASB issued ASU No. 2021 - 10, Government Assistance (Topic 832 ): Disclosures by Business Entities about Government Assistance . This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958 - 605. Our effective date for adoption of this ASU is our fiscal year beginning December 4, 2022 with early adoption permitted. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and determined it will not have a material impact.     9 Table of Contents       Note 2: Acquisitions   Apollo   On January 26, 2022, we acquired Apollo Chemicals Limited, Apollo Roofing Solutions Limited and Apollo Construction Solutions Limited (collectively, "Apollo") for a base purchase price of GBP 151,214 , or approximately $ 203,573 , which was funded through borrowings on our credit facility. The agreement requires us to pay an additional GBP 1,500 , or approximately $ 2,019 , following the completion of certain environmental studies. Apollo, headquartered in Tamworth, UK, is a manufacturer of liquid adhesives, coatings and primers for the roofing, industrial and construction markets. Apollo is expected to enhance our position in key high-value, high-margin markets in the UK and throughout Europe. The acquisition fair value measurement was preliminary as of February 26, 2022. The acquisition will be included in our Construction Adhesives operating segment.    The following table summarizes the preliminary fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:       Amounts   Cash   $ 12,165   Current assets     18,873   Property, plant and equipment     7,877   Goodwill     104,885   Other intangibles         Customer relationships     82,256   Trademarks/trade names     2,154       Technology     9,558   Current liabilities     ( 8,293 ) Other liabilities     ( 23,883 ) Total   $ 205,592     The expected useful lives of the acquired intangible assets are 12 years for customer relationships and technology and 10 years for trademarks/trade names.   Based on the fair value measurement of the assets acquired and liabilities assumed, we allocated $ 104,885 to goodwill for the expected synergies from combining Apollo with our existing business. Such goodwill is not deductible for tax purposes. The goodwill was assigned to our Construction Adhesives operating segment. The Apollo acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.   Fourny NV   On January 11, 2022, we acquired Fourny NV ("Fourny") for a base purchase price of EUR 12,867 , or approximately $ 14,627 , which was funded through existing cash. The agreement requires us to pay an additional EUR 3,100 , or approximately $ 3,524 , 18 months following the date of acquisition. Fourny, headquartered in Willebroek, Belgium, is a manufacturer of construction and automotive adhesives . Fourny is expected to enhance our position in key high-value, high-margin markets in Europe. The acquisition fair value measurement was preliminary as of February 26, 2022 and includes intangible assets of $ 10,799 , goodwill of $ 6,497 , cash of $ 75 and other net assets of $ 780 . Goodwill is not ded uctible for tax purposes. Fourny is recorded in our Construction Adhesives operating segment. The Fourny acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.   Tissue Seal, LLC   On  November 30, 2021, we acquired certain assets of Tissue Seal, LLC ("TissueSeal") for a base purchase price of $ 22,167 , which was funded through existing cash. The agreement requires us to pay an additional $ 2,475  on the first anniversary of the acquisition and contingent consideration of up to $ 500 on November 30, 2024 based on certain agreement provisions. TissueSeal, headquartered in Ann Arbor, Michigan, is a distributor of topical tissue adhesives and sutures. With this acquisition, we add TissueSeal's regulatory clearances, customer and distribution relationships, regulatory approvals and trademarks into our portfolio of products. T he acquisition fair value measurement was preliminary as of February 26, 2022 and includes intangible assets of $ 11,161 , goodwill of $ 13,764  and other net assets of $ 217 . Goodwill is de ductible for tax purposes. See Note 11 for further discussion of the fair value of the contingent consideration liability. TissueSeal is recorded in our Hygiene, Health and Consumable Adhesives operating segment. The TissueSeal acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.   STR Holdings, Inc.   On January 13, 2021, we acquired certain assets of STR Holding, Inc. ("STR") for a base purchase price of $ 5,445  which was funded through existing cash. The agreement required us to pay an additional $ 800 on the first anniversary of the acquisition and contingent consideration of up to $ 1,700 based on certain agreement provisions. STR, headquartered in Enfield, Connecticut, is a manufacturer of encapsulant products used in the solar industry. The acquisition fair value measurement, which includes intangible assets of $ 6,700  and other net assets of $ 1,245 , was final as of November 27, 2021. The agreement provisions for the contingent consideration were met, and as a result, $ 1,700 was paid as of November 27, 2021. No goodwill was recorded for this acquisition. STR is reported in our Engineering Adhesives operating segment. The STR acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.    D.H.M. Adhesives, Inc .    On February 3, 2020, we acquired certain assets of D.H.M. Adhesives, Inc. (“D.H.M.”) for approximately $ 9,500 which was funded through existing cash. In addition, the agreement requires us to pay contingent consideration of up to approximately $ 8,100 based upon a formula related to revenue during the fiscal years ended November 27, 2021 and December 3, 2022. D.H.M., headquartered in Calhoun, Georgia, is a provider of hotmelt adhesives. The acquisition fair value measurement was final as of May 30, 2020 and includes goodwill of $ 1,063 and customer relationship intangible of $ 11,900 . The fair value of the contingent consideration as of the date of acquisition was $ 5,000 resulting in a final purchase price of $ 14,500 . As of November 27, 2021, the agreement provisions for the contingent consideration were met, and as a result, $ 8,100 was paid during the period ended February 26, 2022. Goodwill is deductible for tax purposes. D.H.M. and the related goodwill are reported in our Hygiene, Health and Consumable Adhesives operating segment. The D.H.M acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.     Note 3: Restructuring Actions   The Company has approved restructuring plans consisting of consolidation plans, organizational changes and other actions related to the reorganization of our business into three segments, the integration of the operations of Royal Adhesives with the operations of the Company and other actions to optimize operations. The following table summarizes the pre-tax charges under these restructuring plans by income statement classification:       Three Months Ended       February 26, 2022     February 27, 2021   Cost of sales   $ ( 152 )   $ 270   Selling, general and administrative     ( 89 )     1,547       $ ( 241 )   $ 1,817     The restructuring charges are all recorded in Corporate Unallocated for segment reporting.   A summary of the restructuring liability is presented below:       Employee-Related     Other     Total   Balance at November 28, 2020   $ 5,834     $ 248     $ 6,082   Expenses incurred     ( 807 )     1,594       787          Non-cash charges     -       ( 135 )     ( 135 ) Cash payments     ( 3,917 )     ( 1,707 )     ( 5,624 ) Foreign currency translation     ( 15 )     -       ( 15 ) Balance at November 27, 2021     1,095       -       1,095   Expenses incurred     ( 241 )     -       ( 241 ) Cash payments     ( 288 )     -       ( 288 ) Foreign currency translation     ( 18 )     -       ( 18 ) Balance at February 26, 2022   $ 548     $ -     $ 548     10 Table of Contents   Non-cash charges include accelerated depreciation resulting from the cessation of use of certain long-lived assets. Restructuring liabilities have been classified as a component of other accrued expenses in the Consolidated Balance Sheets.     Note 4: Inventories   The composition of inventories is as follows:       February 26,     November 27,       2022     2021   Raw materials   $ 276,638     $ 226,723   Finished goods     271,230       221,681   Total inventories   $ 547,868     $ 448,404       Note 5: Goodwill and Other Intangible Assets   The goodwill activity by reportable segment for the  three months ended February 26, 2022 is presented below:       Hygiene, Health                               and Consumable     Engineering     Construction               Adhesives     Adhesives     Adhesives     Total   Balance at November 27, 2021   $ 325,470     $ 662,021     $ 311,354     $ 1,298,845       TissueSeal acquisition     13,764       -       -       13,764       Fourny acquisition     -       -       6,497       6,497       Apollo acquisition     -       -       104,885       104,885   Foreign currency translation effect     651       1,756       ( 462 )     1,945   Balance at February 26, 2022   $ 339,885     $ 663,777     $ 422,274     $ 1,425,936     Balances of amortizable identifiable intangible assets, excluding goodwill and other non-amortizable intangible assets, are as follows:       February 26, 2022       Purchased                                       Technology     Customer                           Amortizable Intangible Assets   and Patents     Relationships     Trade Names     Other     Total   Original cost   $ 100,423     $ 1,035,413     $ 58,223     $ 11,149     $ 1,205,208   Accumulated amortization     ( 45,714 )     ( 350,052 )     ( 18,951 )     ( 5,593 )     ( 420,310 ) Net identifiable intangibles   $ 54,709     $ 685,361     $ 39,272     $ 5,556     $ 784,898         November 27, 2021       Purchased                                       Technology     Customer                           Amortizable Intangible Assets   and Patents     Relationships     Trade Names     Other     Total   Original cost   $ 115,980     $ 932,644     $ 63,543     $ 11,343     $ 1,123,510   Accumulated amortization     ( 62,364 )     ( 335,143 )     ( 33,786 )     ( 5,635 )     ( 436,928 ) Net identifiable intangibles   $ 53,616     $ 597,501     $ 29,757     $ 5,708     $ 686,582     Amortization expense with respect to amortizable intangible assets was $ 17,792  and $ 17,896  for the three months ended February 26, 2022 and February 27, 2021 , respectively.   11 Table of Contents   Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for the next five fiscal years is as follows:       Remainder                                           Fiscal Year   2022     2023     2024     2025     2026     Thereafter   Amortization expense   $ 57,478     $ 73,948     $ 69,010     $ 66,434     $ 59,601     $ 458,427     Non-amortizable intangible assets as of  February 26, 2022 and November 27, 2021 are $ 491  and $ 493 , respectively, and are related to trademarks and trade names. The change in non-amortizable assets as of February 26, 2022 compared to November 27, 2021 was due to changes in foreign currency exchange rates.     Note 6: Components of Net Periodic Benefit related to Pension and Other Postretirement Benefit Plans       Three Months Ended February 26, 2022 and February 27, 2021                                       Other       Pension Benefits     Postretirement       U.S. Plans     Non-U.S. Plans     Benefits   Net periodic cost (benefit):   2022     2021     2022     2021     2022     2021   Service cost   $ -     $ -     $ 720     $ 833     $ -     $ 5   Interest cost     2,368       2,325       789       733       184       205   Expected return on assets     ( 7,117 )     ( 7,781 )     ( 1,747 )     ( 3,077 )     ( 2,719 )     ( 2,235 ) Amortization:                                                 Prior service cost (benefit)     ( 1 )     ( 1 )     16       17       -       -   Actuarial loss     1,013       799       649       1,022       ( 845 )     18   Net periodic benefit   $ ( 3,737 )   $ ( 4,658 )   $ 427     $ ( 472 )   $ ( 3,380 )   $ ( 2,007 )   Service cost is included with employee compensation cost in cost of sales and selling, general and administrative expenses in the Consolidated Statements of Income. The components of our net periodic defined benefit pension and postretirement benefit costs other than service cost are presented in other income, net in the Consolidated Statements of Income.   12 Table of Contents       Note 7: Accumulated Other Comprehensive Income (Loss)   The following table provides details of total comprehensive income (loss):        Three Months Ended February 26, 2022     Three Months Ended February 27, 2021                               Non-                             Non-                               controlling                             controlling       H.B. Fuller Stockholders     Interest     H.B. Fuller Stockholders     Interest       Pre-tax     Tax     Net     Net     Pre-tax     Tax     Net     Net   Net income attributable to H.B. Fuller and non-controlling interest                   $ 38,306     $ 14                     $ 29,791     $ 15   Foreign currency translation adjustment¹   $ 6,540     $ -       6,540       ( 10 )   $ 23,147     $ -       23,147       ( 10 ) Defined benefit pension plans adjustment²     833       ( 344 )     489       -       1,855       ( 480 )     1,375       -   Interest rate swap³     8,255       ( 2,024 )     6,231       -       5,537       ( 1,357 )     4,180       -   Cross currency swaps³     ( 2,115 )     32       ( 2,083 )     -       ( 1,062 )     16       ( 1,046 )     -   Other comprehensive income (loss)   $ 13,513     $ ( 2,336 )   $ 11,177     $ ( 10 )   $ 29,477     $ ( 1,821 )   $ 27,656     $ ( 10 ) Comprehensive income (loss)                   $ 49,483     $ 4                     $ 57,447     $ 5     ¹ Income taxes are not provided for foreign currency translation relating to permanent investments in international subsidiaries. ² Loss reclassified from accumulated other comprehensive income ("AOCI") into earnings as part of net periodic cost related to pension and other postretirement benefit plans is reported in cost of sales and SG&A expense. ³ Income (loss) reclassified from AOCI into earnings is reported in other income, net.   13 Table of Contents   The components of accumulated other comprehensive loss are as follows:       February 26, 2022                       Non-               H.B. Fuller     controlling       Total     Stockholders     Interest   Foreign currency translation adjustment   $ ( 125,820 )   $ ( 125,727 )   $ ( 93 ) Interest rate swap, net of taxes of $1,200     ( 3,693 )     ( 3,693 )     -   Cash flow hedges, net of taxes of ($21)     1,400       1,400       -   Defined benefit pension plans adjustment, net of taxes of $63,581     ( 112,709 )     ( 112,709 )     -   Reclassification of AOCI tax effects     ( 18,341 )     ( 18,341 )     -   Accumulated other comprehensive loss   $ ( 259,163 )   $ ( 259,070 )   $ ( 93 )       November 27, 2021                       Non-               H.B. Fuller     controlling       Total     Stockholders     Interest   Foreign currency translation adjustment   $ ( 132,370 )   $ ( 132,267 )   $ ( 103 ) Interest rate swap, net of taxes of $3,224     ( 9,924 )     ( 9,924 )     -   Cash flow hedges, net of taxes of ($53)     3,483       3,483       -   Defined benefit pension plans adjustment, net of taxes of $63,925     ( 113,198 )     ( 113,198 )     -   Reclassification of AOCI tax effects     ( 18,341 )     ( 18,341 )     -   Accumulated other comprehensive loss   $ ( 270,350 )   $ ( 270,247 )   $ ( 103 )     Note 8: Income Taxes   Income tax expense for the  three months ended February 26, 2022  includes $ 2,901 of discrete tax benefit, relating to legal entity mergers offset by various foreign tax matters. Excluding the discrete tax benefit, the overall effective tax rate was  27.8 percent for the three months ended February 26, 2022 .     Income tax expense for the three months ended February 27, 2021 includes $ 42  of discrete tax expense, relating to the revaluation of cross-currency swap agreements due to appreciation of the Euro versus the U.S. Dollar and various foreign tax matters. Excluding the discrete tax expense, the overall effective tax rate was  27.4  percent for the three months ended February 27, 2021 .   As of  February 26, 2022 , we had a liability of $ 14,703  recorded for gross unrecognized tax benefits (excluding interest) compared to $ 13,281  as of November 27, 2021 . As of February 26, 2022 and November 27, 2021 , we had accrued $ 3,131 and $ 2,881 of gross interest relating to unrecognized tax benefits, respectively.   14 Table of Contents       Note 9: Earnings Per Share   A reconciliation of the common share components for the basic and diluted earnings per share calculations is as follows:       Three Months Ended       February 26,     February 27,   (Shares in thousands)   2022     2021   Weighted-average common shares - basic     53,353       52,492   Equivalent shares from share-based compensations plans     2,042       847   Weighted-average common and common equivalent shares diluted     55,395       53,339     Basic earnings per share is calculated by dividing net income attributable to H.B. Fuller by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is based upon the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to share-based compensation awards. We use the treasury stock method to calculate the effect of outstanding shares, which computes total employee proceeds as the sum of (a) the amount the employee must pay upon exercise of the award and (b) the amount of unearned share-based compensation costs attributed to future services. Share-based compensation awards for which total employee proceeds exceed the average market price over the applicable period have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share.   Share-based compensation awards of  700,250 and 2,789,184  shares for the three months ended February 26, 2022 and February 27, 2021 , respectively, were excluded from diluted earnings per share calculations because they were antidilutive.     Note 10: Financial Instruments   Overview   As a result of being a global enterprise, our earnings, cash flows and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables.   We use foreign currency forward contracts, cross-currency swaps and interest rate swaps to manage risks associated with foreign currency exchange rates and interest rates. We do not hold derivative financial instruments of a speculative nature or for trading purposes. We record derivatives as assets and liabilities on the balance sheet at fair value. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Cash flows from derivatives are classified in the Consolidated Statement of Cash Flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships. We evaluate hedge effectiveness at inception and on an ongoing basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Hedge ineffectiveness, if any, is recorded in earnings.   We are exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swap agreements. We select investment-grade multinational banks and financial institutions as counterparties for derivative transactions and monitor the credit quality of each of these banks on a periodic basis as warranted. We do not anticipate nonperformance by any of these counterparties, and valuation allowances, if any, are de minimis.   15 Table of Contents   Cash Flow Hedges   As of February 26, 2022 , we had cash flow hedges of four  cross-currency swap agreements effective October 20, 2017 to convert a notional amount of $ 267,860 of foreign currency denominated intercompany loans into U.S. dollars, which mature in 2022.  As of February 26, 2022 , the combined fair value of the swaps was an asse t of $ 13,503   and was included in other current assets in the Consolidated Balance Sheets. The swaps were designated as cash flow hedges for accounting treatment. The lesser amount between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps is recorded in accumulated other comprehensive income (loss) in the Consolidated Balance Sheets and in other net cash provided by operating activities in the Consolidated Statement of Cash Flows. The differ ences between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps are recorded as other income, net in the Consolidated Statements of Income. In a perfectly effective hedge relationship, the two fair value calculations would exactly offset each other. Any difference in the calculation represents hedge ineffectiveness. The amount in accumulated other comprehensive income (loss) related to cross-currency swaps was a gain of $ 1,400  as of February 26, 2022 . The estimated net amount of the existing gain that is reported in accumulated other comprehensive income (loss) as of February 26, 2022 that is expected to be reclassified into earnings within the next twelve month s is $ 1,400 .  As of February 26, 2022 , we do not believe any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.   The following table summarizes the cross-currency swaps outstanding as of February 26, 2022 :     Fiscal Year of         Notional             Expiration   Interest Rate     Value     Fair Value   Pay EUR 2022   3.00 %     $ 267,860     $ 13,503   Receive USD   5.1803 %                     On February 27, 2018, we entered into an interest rate swap agreement to convert $ 200,000 of our $ 2,150,000 Term Loan B to a fixed interest rate of 4.589 percent. During the second  quarter of 2021, we settled a portion of this interest rate swap as the debt underlying this swap was less than the swap value due to debt paydown. We settled the ineffective portion of the interest rate swap by making a cash payment of $ 378 and recorded that payment to interest expense in our Consolidated Statements of Income during the second quarter of  2021. On October 20, 2017, we entered into interest rate swap agreements to convert $ 1,050,000 , which was amortized down to $ 800,000 on October 20, 2021,  of our $ 2,150,000 Term Loan B to a fixed interest rate of 4.0275 percent. The combined fair value of the interest rate swaps was a liabi lity of $ 4,900   at February 26, 2022 and was included in other liabilities in the Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as cash flow hedges. We are applying the hypothetical derivative method to assess hedge effectiveness for these interest rate swaps. Changes in the fair value of a hypothetically perfect swap with terms that match the critical terms of our $ 1,125,000 variable rate Term Loan B are compared with the change in the fair value of the swaps.   16 Table of Contents   On April 23, 2018, we amended our Term Loan B Credit Agreement to reduce the interest rate from LIBOR plus 2.25 percent to LIBOR plus 2.00 percent. Fixed interest rates related to swap agreements disclosed have been updated to reflect the amendment.   The amounts of pretax gains (losses) recognized in Comprehensive Income related to derivative instruments designated as cash flow hedges are as follows:       Three Months Ended       February 26, 2022     February 27, 2021   Cross-currency swap contracts   $ ( 2,115 )   $ ( 1,062 ) Interest rate swap contracts     8,255       5,537     Fair Value Hedges   On February 12, 2021, we entered into interest rate swap agreements to convert our $ 300,000  Public Notes that were issued on October  20, 2020 to a variable interest rate of 1 -month LIBOR plus 3.28 percent. The combined fair value of the interest rate swaps was a liability of $ 21,844  at  February 26, 2022 , and was included in other liabilities in the Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as fair value hedges. We apply the short cut method and assume hedge effectiveness. Changes in the fair value of a hypothetically perfect swap with terms that match the critical terms of our $ 300,000 fixed rate Public Notes are compared with the change in the fair value of the swaps.   Derivatives Not Designated As Hedging Instruments   We use foreign currency forward contracts to offset our exposure to the change in value of certain foreign currency denominated assets and liabilities held at foreign subsidiaries that are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Foreign currency forward contracts are recorded as assets and liabilities on the balance sheet at fair value. Changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. See Note 11  for fair value amounts of these derivative instruments.   As of February 26, 2022 , we had forward foreign currency contracts maturing between February 28, 2022 and December 13, 2022. Th e mark-to-market effect associated with these contracts was largely offset by the underlying transaction gains and losses resulting from the foreign currency exposures for which these contracts relate.    The amounts of pretax gains (losses) recognized in other income, net related to derivative instruments not designated as hedging instruments for the  three months ended February 26, 2022 and February 27, 2021 were $ 4,237  a nd $ ( 5,205 ), respectively.   Concentrations of credit risk with respect to trade accounts receivable are limited due to the large number of entities in the customer base and their dispersion across many different industries and countries. As of February 26, 2022 , there were no significant concentrations of credit risk.   17 Table of Contents       Note 11: Fair Value Measurements   Overview   Estimates of fair value for financial assets and liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value and requires certain disclosures. The framework discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:     ● Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.   ● Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.   ● Level 3: Unobservable inputs that reflect management’s assumptions, and include situations where there is little, if any, market activity for the asset or liability.   Balances Measured at Fair Value on a Recurring Basis   The following table presents information about our financial assets and liabilities that are measured at fair value on a recurring basis as of February 26, 2022 and November 27, 2021 , and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value.       February 26,     Fair Value Measurements Using:   Description   2022     Level 1     Level 2     Level 3   Assets:                                 Marketable securities   $ 2,923     $ 2,923     $ -     $ -   Foreign exchange contract assets     5,134       -       5,134       -   Cross-currency cash flow hedge assets     13,503       -       13,503       -                                     Liabilities:                                 Foreign exchange contract liabilities   $ 897     $ -     $ 897     $ -   Interest rate swaps, cash flow hedge liabilities     4,900       -       4,900       -   Interest rate swaps, fair value hedge liabilities     21,844       -       21,844       -   Contingent consideration liability     500       -       -       500         November 27,     Fair Value Measurements Using:   Description   2021     Level 1     Level 2     Level 3   Assets:                                 Marketable securities   $ 2,079     $ 2,079     $ -     $ -   Foreign exchange contract assets     5,725       -       5,725       -   Cross-currency cash flow hedge assets     14,496       -       14,496       -                                     Liabilities:                                 Foreign exchange contract liabilities   $ 6,082     $ -     $ 6,082     $ -   Interest rate swaps, cash flow hedge liabilities     12,366       -       12,366         Interest rate swaps, fair value hedge liabilities     10,539       -       10,539       -   Contingent consideration liability     8,100       -       -       8,100     Adjustments to the fair value of contingent consideration are recorded to selling, general and administrative expenses in the Statement of Income.    18 Table of Contents   The valuation of our contingent consideration liability related to the acquisition of TissueSeal resulted in a fair value of $ 500 as of  February 26, 2022 . As of November 27, 2021, the agreement provisions for the D.H.M contingent consideration were met, and as a result, $ 8,100 was paid during the period ended February 26, 2022. See Note 2 for further discussion regarding our acquisitions.  The following table provides details of the contingent consideration liabilities:          Amounts   Balance at November 27, 2021   $ 8,100   Acquisition     500   Payment of contingent consideration     ( 8,122 ) Mark to market adjustment     22   Balance at February 26, 2022   $ 500       Balances Measured at Fair Value on a Nonrecurring Basis   We measure certain assets and liabilities at fair value on a nonrecurring basis. These assets include intangible assets acquired in an acquisition.  The identified intangible assets of customer relationships, technology and tradenames acquired in connection with our acquisitions were measured using unobservable (Level  3 ) inputs.  The fair value of the intangible assets was calculated using either the income approach. Significant inputs include estimated revenue growth rates, gross margins, operating expenses, attrition rate, royalty rate and discount rate.     See Note  2  for further discussion regarding our acquisitions.   Balances Disclosed at Fair Value   Long-term debt had an estimated fair value of $ 1,905,402  and $ 1,618,291 as of February 26, 2022 and November 27, 2021 , respectively. The fair value of long-term debt is based on quoted market prices for the same or similar issues or on the current rates offered for debt of similar maturities. The estimated fair value of these long-term obligations is not necessarily indicative of the amount that would be realized in a current market exchange.     Note 12: Commitments and Contingencies   Environmental Matters     From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. We review the circumstances of each individual site, considering the number of parties involved, the level of potential liability or our contribution relative to the other parties, the nature and magnitude of the hazardous substances involved, the method and extent of remediation, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred. Also, from time to time, we are identified as a potentially responsible party (“PRP”) under the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish an undiscounted financial provision. We recorded liabilities of $ 6,522 and $ 6,603  as of February 26, 2022 and November 27, 2021 , respectively, for probable and reasonably estimable environmental remediation costs. Of the amount reserved, $ 3,172 and $ 3,333  as of February 26, 2022 and November 27, 2021 , respectively, is attributable to a facility we own in Simpsonville, South Carolina as a result of our Royal Adhesives acquisition that is a designated site under CERCLA.   Currently, we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites. In addition, we are engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.   Other Legal Proceedings     From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including the asbestos litigation described in the following paragraphs, will not have a material adverse effect on our results of operations, financial condition or cash flow.   19 Table of Contents   We have been named as a defendant in lawsuits in which plaintiffs have alleged injury due to products containing asbestos manufactured more than 35 years ago. The plaintiffs generally bring these lawsuits against multiple defendants and seek damages (both actual and punitive) in very large amounts. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable injuries or that the injuries suffered were the result of exposure to products manufactured by us. We are typically dismissed as a defendant in such cases without payment. If the plaintiff presents evidence indicating that compensable injury occurred as a result of exposure to our products, the case is generally settled for an amount that reflects the seriousness of the injury, the length, intensity and character of exposure to products containing asbestos, the number and solvency of other defendants in the case, and the jurisdiction in which the case has been brought.   A significant portion of the defense costs and settlements in asbestos-related litigation is paid by third parties, including indemnification pursuant to the provisions of a 1976 agreement under which we acquired a business from a third party. Currently, this third party is defending and paying settlement amounts, under a reservation of rights, in most of the asbestos cases tendered to the third party.   In addition to the indemnification arrangements with third parties, we have insurance policies that generally provide coverage for asbestos liabilities, including defense costs. Historically, insurers have paid a significant portion of our defense costs and settlements in asbestos-related litigation. However, certain of our insurers are insolvent. We have entered into cost-sharing agreements with our insurers that provide for the allocation of defense costs and settlements and judgments in asbestos-related lawsuits. These agreements require, among other things, that we fund a share of defense costs, settlements and judgments allocable to years in which the responsible insurer is insolvent.   A summary of the number of and settlement amounts for asbestos-related lawsuits and claims is as follows:       Three Months Ended     3 Years Ended       February 26, 2022     February 27, 2021     November 27, 2021   Lawsuits and claims settled     -       2       14   Settlement amounts   $ -     $ 85     $ 639   Insurance payments received or expected to be received   $ -     $ 55     $ 434     We do not believe that it would be meaningful to disclose the aggregate number of asbestos-related lawsuits filed against us because relatively few of these lawsuits are known to involve exposure to asbestos-containing products that we manufactured. Rather, we believe it is more meaningful to disclose the number of lawsuits that are settled and result in a payment to the plaintiff. To the extent we can reasonably estimate the amount of our probable liabilities for pending asbestos-related claims, we establish a financial provision and a corresponding receivable for insurance recoveries.    Based on currently available information, we have concluded that the resolution of any pending matter, including asbestos-related litigation, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.     Note 13: Segments   We are required to report segment information in the same way that we internally organize our business for assessing performance and making decisions regarding allocation of resources. Revenue and operating income of each of our segments are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance. Segment operating income is identified as gross profit less SG&A expenses. Corporate expenses, other than those included in Corporate Unallocated, are allocated to each operating segment. Consistent with our internal management reporting, Corporate Unallocated amounts include business acquisition and integration costs, organizational restructuring charges and project costs associated with our implementation of Project ONE. Corporate assets are not allocated to the operating segments. Inter-segment revenues are recorded at cost plus a markup for administrative costs.   We have  three reportable segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. The business components within each operating segment are managed to maximize the results of the overall operating segment rather than the results of any individual business component of the operating segment. Results of individual components of each operating segment are subject to numerous allocations of segment-wide costs that may or may not have been focused on that particular component for a particular reporting period. The costs for these allocated resources are not tracked on a "where-used" basis as financial performance is assessed at the total operating segment level.   20 Table of Contents   The table below provides certain information regarding net revenue and operating income (loss) for each of our operating segments.        Three Months Ended       February 26, 2022     February 27, 2021       Net     Operating     Net     Operating       Revenue     Income (Loss)     Revenue     Income (Loss)   Hygiene, Health and Consumable Adhesives   $ 389,538     $ 32,213     $ 335,669     $ 29,912   Engineering Adhesives     353,977       32,572       312,663       30,417   Construction Adhesives     112,967       4,356       77,572       ( 4,703 ) Total segment   $ 856,482     $ 69,141     $ 725,904     $ 55,626   Corporate Unallocated 1     -       ( 12,142 )     -       ( 7,276 ) Total   $ 856,482     $ 56,999     $ 725,904     $ 48,350     1 Consistent with our internal management reporting, Corporate Unallocated amounts in the tables above include charges that are not allocated to the Company’s reportable segments.    The table below provides a reconciliation of operating income to income before income taxes and income from equity method investments:       Three Months Ended       February 26,     February 27,       2022     2021   Operating income   $ 56,999     $ 48,350   Other income, net     6,142       7,869   Interest expense     ( 18,196 )     ( 20,361 ) Interest income     1,940       2,659   Income before income taxes and income from equity method investments   $ 46,885     $ 38,517     21 Table of Contents   We view the following disaggregation of net revenue by geographic region as useful to understanding the composition of revenue recognized during the respective reporting periods:       Three Months Ended February 26, 2022                                         Hygiene, Health                               and Consumable     Engineering     Construction               Adhesives     Adhesives     Adhesives     Total                                     Americas   $ 220,694     $ 133,328     $ 95,578     $ 449,600   EIMEA     114,653       115,820       11,217       241,690   Asia Pacific     54,191       104,829       6,172       165,192   Total   $ 389,538     $ 353,977     $ 112,967     $ 856,482         Three Months Ended February 27, 2021                                         Hygiene, Health                               and Consumable     Engineering     Construction               Adhesives     Adhesives     Adhesives     Total                                     Americas   $ 182,022     $ 113,126     $ 67,032     $ 362,180   EIMEA     95,973       101,759       4,727       202,459   Asia Pacific     57,674       97,778       5,813       161,265   Total   $ 335,669     $ 312,663     $ 77,572     $ 725,904     22 Table of Contents       Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations   Overview   The Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the MD&A included in our Annual Report on Form 10-K for the year ended November 27, 2021 for important background information related to our business.    Net revenue in the first quarter of 2022 increased 18.0 percent from the first quarter of 2021. Net revenue increased 14.7 percent due to price, 6.1 percent due to sales volume and 0.9 percent due to the acquisition of Fourny and Apollo. Negative currency effects of 3.7 percent compared to the first quarter of 2021 were primarily driven by a weaker Euro, Turkish lira and Argentinian peso, partially offset by a stronger Chinese renminbi compared to the U.S. dollar . Gross profit margin decreased 160  basis points primarily due to higher ra w material costs partially offset by higher sales volume.    Net income attributable to H.B. Fuller in the first quarter of 2022 was $38.3 million compared to $29.8 million in the first quarter of 2021. On a diluted earnings per share basis, the first quarter of 2022 was $0.69 per share compared to $0.56 per share for the first quarter of 2021.   Market Conditions     On March 11, 2020, the World Health Organization declared the outbreak of the novel coronavirus ("COVID-19") a pandemic. Throughout fiscal year 2021, the COVID-19 pandemic had a significant disruptive impact on global economies, supply chains and industrial production. Although government restrictions have been relaxed, it is currently not possible to estimate additional impacts this outbreak may have on our business. We continue to effectively manage our global operations focusing on the health and safety of our employees and ensuring business continuity across our supplier, manufacturing and distribution networks.   See "Risk Factors" in Item 1A in our Annual Report on Form 10-K for the year ended November 27, 2021 as filed with the Securities and Exchange Commission for further information of the effects of the COVID-19 pandemic on our business including raw material cost and availability.   Restructuring Plan   During the fourth quarter of 2019, we approved a restructuring plan related to organizational changes and other actions to optimize operations in connection with the realignment of the Company into three global business units (“2020 Restructuring Plan”). We have incurred costs of $18.9  million under this plan as of February 26, 2022. We expect to incur total costs of approximately $20.0 million ($15.8 million after-tax), which includes cash expenditures for severance and related employee costs globally, costs related to streamlining of processes, and other restructuring-related costs. The 2020 Restructuring Plan was implemented in the fourth quarter of 2019 and is currently expected to be completed in fiscal 2022.   23 Table of Contents   Results of Operations   Net revenue:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net revenue   $ 856.5     $ 725.9       18.0 %   We review variances in net revenue in terms of changes related to sales volume, product pricing, business acquisitions and divestitures (“M&A”) and changes in foreign currency exchange rates. The following table shows the net revenue variance analysis for the first quarter of 2022 compared to the same periods in 2021:       Three Months Ended       February 26, 2022 vs. February 27, 2021   Organic growth     20.8 % M&A     0.9 % Currency     (3.7 )% Total     18.0 %   Organic growth was 20.8 percent in the first quarter of 2022 compared to the first quarter of 2021 driven by a 38.3 percent increase in Construction Adhesives, a 20.7 percent increase in Hygiene, Health and Consumable Adhesives and a 16.5 percent increase in Engineering Adhesives. The increase is predominately driven by an increase in product pricing and sales volume. The 0.9 percent increase from M&A is due to the acquisition of Fourny and Apollo.  The negative 3.7 percent currency impact was primarily driven by a weaker Euro, Turkish lira and Argentinian peso, partially offset by a stronger Chinese renminbi compared to the U.S. dollar.   Cost of sales:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Raw materials   $ 491.0     $ 385.0       27.5 % Other manufacturing costs     152.6       148.5       2.8 % Cost of sales   $ 643.6     $ 533.5       20.6 % Percent of net revenue     75.1 %     73.5 %           Cost of sales in the first quarter of 2022 compared to the first quarter of 2021 increased 160 basis points as a percentage of net revenue. Raw material cost as a percentage of net revenue increased 430 basis points in the first quarter of 2022 compared to the first quarter of 2021 due to higher raw material costs. Other manufacturing costs as a percentage of revenue decreased 270 basis points in the first quarter of 2022 compared to the first quarter of 2021 due to higher net revenue.     24 Table of Contents   Gross profit:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Gross profit   $ 212.9     $ 192.4       10.7 % Percent of net revenue     24.9 %     26.5 %           Gross profit in the first quarter of 2022 increased 10.7 percent and gross profit margin decreased 160 basis points compared to the first quarter of 2021. The decrease in gross profit margin was primarily due to higher raw material costs partially offset by higher sales volume.   Selling, general and administrative (SG&A) expenses:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   SG&A   $ 155.9     $ 144.0       8.3 % Percent of net revenue     18.2 %     19.8 %           SG&A expenses for the first quarter of 2022 increased $11.9 million, or 8.3 percent, compared to the first quarter of 2021. The increase is primarily due to higher compensation and acquisition project costs and the impact of the Fourny and Apollo acquisitions.   Other income, net:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Other income, net   $ 6.1     $ 7.9       (22.8 )%   Other income, net in the first quarter of 2022 included $7.4 million of net defined benefit pension benefits and $0.2 million of other income, partially offset by $1.5 million of currency transaction losses. Other income, net in the first quarter of 2021 included $7.9 million of net defined benefit pension benefits and $1.8 million of other income, offset by $1.8 million of currency transaction losses.   Interest expense:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Interest expense   $ 18.2     $ 20.4       (10.8 )%   25 Table of Contents   Interest expense in the first quarter of 2022 was $18.2 million compared to $20.4 million in the first quarter of 2021. Interest expense in the first quarter of 2022 compared to the first quarter of 2021 was lower due to lower interest rates.   Interest income:       Three Months Ended     February 26,   February 27,   2022 vs ($ in millions)   2022   2021   2021 Interest income   $ 1.9   $ 2.7   (29.6)%   Interest income in the first quarter of 2022 was $1.9 million. Interest income in the first quarter of 2021 was $2.7 million.   Income taxes:       Three Months Ended     February 26,     February 27,   2022 vs ($ in millions)   2022     2021   2021 Income taxes   $ 10.1     $ 10.6   (4.7)% Effective tax rate     21.6 %     27.5 %     Income tax expense of $10.1 million in the first quarter of 2022 includes $2.9 million of discrete tax benefit. Excluding the discrete tax benefit, the overall effective tax rate was 27.8 percent. The discrete tax benefit relates to impacts of legal entity mergers offset by various foreign tax matters. Income tax expense of $10.6 million in the first quarter of 2021 includes less than $0.1 million of discrete tax expense relating to the revaluation of cross-currency swap agreements due to appreciation of the Euro versus the U.S. Dollar and various foreign tax matters. Excluding the discrete tax expense, the overall effective tax rate was 27.4 percent.   Income from equity method investments:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Income from equity method investments   $ 1.6     $ 1.9       (15.8 )%   The income from equity method investments relates to our 50 percent ownership of the Sekisui-Fuller joint venture in Japan. The lower income for the first quarter of 2022 compared to the same period of 2021 relates to lower net income in our joint venture.   Net income attributable to H.B. Fuller:       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net income attributable to H.B. Fuller   $ 38.3     $ 29.8       28.5 % Percent of net revenue     4.5 %     4.1 %           26 Table of Contents   The net income attributable to H.B. Fuller for the first quarter of 2022 was $38.3 million compared to $29.8 million for the first quarter of 2021. The diluted earnings per share for the first quarter of 2022 was $0.69 per share as compared to $0.56 per share for the first quarter of 2021.     Operating Segment Results   We have three reportable segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. Operating results of each of these segments are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance.    The tables below provide certain information regarding the net revenue and operating income of each of our operating segments.    Corporate Unallocated amounts include business acquisition and integration costs, organizational restructuring charges and project costs associated with our implementation of SAP ONE.   Net Revenue by Segment:       Three Months Ended       February 26, 2022     February 27, 2021       Net     % of     Net     % of   ($ in millions)   Revenue     Total     Revenue     Total   Hygiene, Health and Consumable Adhesives   $ 389.5       46 %   $ 335.7       46 % Engineering Adhesives     354.0       41 %     312.6       43 % Construction Adhesives     113.0       13 %     77.6       11 % Segment total   $ 856.5       100 %   $ 725.9       100 % Corporate Unallocated     -       -       -       -   Total   $ 856.5       100 %   $ 725.9       100 %   Segment Operating Income (Loss):       Three Months Ended       February 26, 2022     February 27, 2021       Segment             Segment               Operating             Operating               Income     % of     Income     % of   ($ in millions)   (Loss)     Total     (Loss)     Total   Hygiene, Health and Consumable Adhesives   $ 32.2       56 %   $ 29.9       62 % Engineering Adhesives     32.6       57 %     30.4       63 % Construction Adhesives     4.4       8 %     (4.7 )     (10 )% Segment total   $ 69.2       121 %   $ 55.6       115 % Corporate Unallocated     (12.2 )     (21 )%     (7.3 )     (15 )% Total   $ 57.0       100 %   $ 48.3       100 %   27 Table of Contents   Hygiene, Health and Consumable Adhesives       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net revenue   $ 389.5     $ 335.7       16.0 % Segment operating income   $ 32.2     $ 29.9       7.7 % Segment operating margin     8.3 %     8.9 %           The following table provides details of the Hygiene, Health and Consumable Adhesives net revenue variances:       Three Months Ended       February 26, 2022 vs. February 27, 2021   Organic growth     20.7 % Currency     (4.7 )% Total     16.0 %   Net revenue increased 16.0 percent in the first quarter of 2022 compared to the first quarter of 2021. The increase in organic growth was attributable primarily to an increase in product pricing and sales volume. The negative currency effect was due to a weaker Euro, Turkish lira and Argentinian peso, partially offset by a stronger Chinese renminbi compared to the U.S. dollar. As a percentage of net revenue, raw material costs increased 490 basis points due to higher raw material costs partially offset by higher net revenue. Other manufacturing costs as a percentage of net revenue decreased 240 basis points primarily due to higher net revenue. SG&A expenses as a percentage of net revenue decreased 190 basis points due to higher net revenue. Segment operating income increased 7.7 percent and segment operating margin as a percentage of net revenue decreased 60 basis points compared to the first quarter of 2021.   Engineering Adhesives       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net revenue   $ 354.0     $ 312.6       13.2 % Segment operating income   $ 32.6     $ 30.4       7.2 % Segment operating margin     9.2 %     9.7 %           28 Table of Contents   The following tables provide details of the Engineering Adhesives net revenue variances:       Three Months Ended       February 26, 2022 vs. February 27, 2021   Organic growth     16.5 % Currency     (3.3 )% Total     13.2 %   Net revenue increased 13.2 percent in the first quarter of 2022 compared to the first quarter of 2021. The increase in organic growth was attributable primarily due to an increase in product pricing and sales volume. The negative currency effect was due to a weaker Euro and Turkish lira, partially offset by a stronger Chinese renminbi compared to the U.S. dollar. Raw material costs as a percentage of net revenue increased 430 basis points due to higher raw material costs partially offset by higher net revenue. Other manufacturing costs as a percentage of net revenue decreased 250 basis points due to higher net revenue. SG&A expenses as a percentage of net revenue decreased 130 basis points due to higher net revenue. Segment operating income increased 7.2 percent and segment operating margin decreased 50 basis points compared to the first quarter of 2021.   Construction Adhesives       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net revenue   $ 113.0     $ 77.6       45.6 % Segment operating income (loss)   $ 4.4     $ (4.7 )     193.6 % Segment operating margin     3.9 %     (6.1 )%           The following tables provide details of the Construction Adhesives net revenue variances:       Three Months Ended       February 26, 2022 vs. February 27, 2021   Organic growth     38.3 % M&A     8.1 % Currency     (0.8 )% Total     45.6 %   Net revenue increased 45.6 percent in the first quarter of 2022 compared to the first quarter of 2021. The increase in organic growth was attributable primarily to an increase in product pricing and sales volume. The increase in net revenue from M&A was due to the acquisition of Fourny and Apollo during the first quarter of 2022.  The negative currency effect was due to a weaker Euro and Australian dollar compared to the U.S. dollar. Raw material costs as a percentage of net revenue increased 280 basis points due to higher raw material costs partially offset by higher net revenue. Other manufacturing costs as a percentage of net revenue decreased 500 basis points due to higher net revenue and the impact of acquisitions. SG&A expenses as a percentage of net revenue decreased 780 basis points due to higher net revenue. Segment operating income increased 193.6 percent and segment operating margin increased 1,000 basis points compared to the first quarter of 2021.   29 Table of Contents   Corporate Unallocated       Three Months Ended       February 26,     February 27,     2022 vs   ($ in millions)   2022     2021     2021   Net revenue   $ -     $ -       0.0 % Segment operating loss   $ (12.2 )   $ (7.3 )     67.1 % Segment operating margin   NMP     NMP             NMP = Non-meaningful percentage   Segment operating loss in the first quarter of 2022 increased 67.1 percent compared to the first quarter of 2021 reflecting increased acquisition project costs.   Financial Condition, Liquidity and Capital Resources   Total cash and cash equivalents as of February 26, 2022 were $63.5 million compared to $61.8 million as of November 27, 2021 and $81.2 million as of February 27, 2021. The majority of the $63.5 million in cash and cash equivalents as of February 26, 2022 was held outside the United States. Total long and short-term debt was $1,914.1 million as of February 26, 2022, $1,616.5 million as of November 27, 2021 and $1,758.2 million as of February 27, 2021. The total debt to total capital ratio as measured by Total Debt divided by (Total Debt plus Total Stockholders’ Equity) was 53.8 percent as of February 26, 2022 as compared to 50.2 percent as of November 27, 2021 and 54.8 percent as of February 27, 2021.   We believe that cash flows from operating activities will be adequate to meet our ongoing liquidity and capital expenditure needs. In addition, we believe we have the ability to obtain both short-term and long-term debt to meet our financing needs for the foreseeable future. Cash available in the United States has historically been sufficient and we expect it will continue to be sufficient to fund U.S. operations, U.S. capital spending and U.S. pension and other postretirement benefit contributions in addition to funding U.S. acquisitions, dividend payments, debt service and share repurchases as needed. For those international earnings considered to be reinvested indefinitely, we currently have no intention to, and plans do not indicate a need to, repatriate these funds for U.S. operations.   Our credit agreements include restrictive covenants that, if not met, could lead to a renegotiation of our credit lines and a significant increase in our cost of financing. At February 26, 2022, we were in compliance with all covenants of our contractual obligations as shown in the following table:   Covenant Debt Instrument Measurement   Result as of February 26, 2022   Secured Indebtedness / TTM EBITDA Term Loan B Credit Agreement Not greater than 5.9     2.9   Secured Indebtedness / TTM EBITDA Revolving Credit Agreement Not greater than 5.9     2.9   TTM EBITDA / Consolidated Interest Expense Revolving Credit Agreement Not less than 2.0     6.0       ● TTM = Trailing 12 months   30 Table of Contents     ● EBITDA for Term Loan B covenant purposes is defined as consolidated net income, plus interest expense, expense for taxes paid or accrued, depreciation and amortization, certain non-cash impairment losses, extraordinary non-cash losses incurred other than in the ordinary course of business, nonrecurring extraordinary non-cash restructuring charges and the non-cash impact of purchase accounting, expenses related to the Royal Adhesives acquisition not to exceed $40.0 million, expenses relating to the integration of Royal Adhesives during the fiscal years ending in 2017, 2018 and 2019 not exceeding $30 million in aggregate, restructuring expenses that began prior to the Royal Adhesives acquisition incurred in fiscal years ending in 2017 and 2018 not exceeding $28 million in aggregate, and non-capitalized charges relating to the SAP implementation during fiscal years ending in 2017 through 2021 not exceeding $13 million in any single fiscal year, minus extraordinary non-cash gains. For the Total Indebtedness / TTM EBITDA ratio, TTM EBITDA is adjusted for the pro forma results from Material Acquisitions and Material Divestitures as if the acquisition or divestiture occurred at the beginning of the calculation period. The full definition is set forth in the Term Loan B Credit Agreement and can be found in the Company’s Form 8-K filing dated October 20, 2017.     ● EBITDA for Revolving Credit Facility covenant purposes is defined as consolidated net income, plus interest expense, expense for taxes paid or accrued, depreciation and amortization, non-cash impairment losses related to long-lived assets, intangible assets or goodwill, nonrecurring or unusual non-cash losses  incurred other than in the ordinary course of business, nonrecurring or unusual non-cash restructuring charges and the non-cash impact of purchase accounting, fees, premiums, expenses and other transaction costs incurred or paid by the borrower or any of its Subsidiaries on the effective date in connection with the  transactions, this agreement and the other loan documents, the 2020 supplemental indenture and the transactions contemplated hereby and thereby, one-time, non-capitalized charges and expenses relating to the Company’s SAP implementation during fiscal years ending in 2017 through 2024, in an amount not  exceeding $15.0 million in any single fiscal year of the Company, charges and expenses relating to the ASP Royal Acquisition, including but not limited to advisory and financing costs, during the Company’s fiscal years ending in 2020 and 2021, in an aggregate amount (as to such years combined) not exceeding $40.0 million, charges and expenses related to the reorganization of the Company and its subsidiaries from five business units to three business units to reduce costs during the Company’s fiscal years ending in 2020 and 2021 in an aggregate amount (as to such years combined) not exceeding $24.0 million, and charges and expenses related to the Company’s manufacturing and operations project to improve delivery, implement cost savings and reduce inventory during the Company’s fiscal years ending in 2020, 2021 and 2022 in an aggregate amount (as to such years combined) not exceeding $15.5 million.     ● Consolidated Interest Expense for the Revolving Credit Facility is defined as the interest expense (including without limitation the portion of capital lease obligations that constitutes imputed interest in accordance with GAAP) of the Company and its subsidiaries calculated on a consolidated basis for such period with respect to all outstanding indebtedness of the Company and its subsidiaries allocable to such period in accordance with GAAP.   We believe we have the ability to meet all of our contractual obligations and commitments in fiscal 2022.   Selected Metrics of Liquidity   Key metrics we monitor are net working capital as a percent of annualized net revenue, trade receivable days sales outstanding (“DSO”), inventory days on hand, free cash flow after dividends and debt capitalization ratio.       February 26,     February 27,       2022     2021   Net working capital as a percentage of annualized net revenue 1     18.5 %     17.9 % Accounts receivable DSO (in days) 2     65       63   Inventory days on hand (in days) 3     81       70   Free cash flow after dividends 4   $ (75.5 )   $ (8.0 ) Total debt to total capital ratio 5     53.8 %     54.8 %   1 Current quarter net working capital (trade receivables, net of allowance for doubtful accounts plus inventory minus trade payables) divided by annualized net revenue (current quarter multiplied by four).   2 Trade receivables net of the allowance for doubtful accounts at the balance sheet date multiplied by 91 (13 weeks) and divided by the net revenue for the quarter.   31 Table of Contents   3 Total inventory multiplied by 91 and divided by cost of sales (excluding delivery costs) for the quarter.   4 Year-to-date net cash provided by operating activities, less purchased property, plant and equipment and dividends paid. See reconciliation of net cash provided by operating activities to free cash flow after dividends below.   5 Total debt divided by (total debt plus total stockholders’ equity).   Free cash flow after dividends, a non-GAAP financial measure, is defined as net cash provided by operations less purchased property, plant and equipment and dividends paid. Free cash flow after dividends is an integral financial measure used by the Company to assess its ability to generate cash in excess of its operating needs, therefore, the Company believes this financial measure provides useful information to investors. The following table reflects the manner in which free cash flow after dividends is determined and provides a reconciliation of free cash flow after dividends to net cash provided by operating activities, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP.   Reconciliation of "Net cash provided by operating activities" to Free cash flow after dividends       Three Months Ended   ($ in millions)   February 26, 2022     February 27, 2021   Net cash provided by operating activities   $ (17.7 )   $ 35.8   Less: Purchased property, plant and equipment     48.9       35.3   Less: Dividends paid     8.9       8.5   Free cash flow after dividends   $ (75.5 )   $ (8.0 )   Summary of Cash Flows   Cash Flows from Operating Activities:         Three Months Ended       February 26,     February 27,   ($ in millions)   2022     2021   Net cash (used in) provided by operating activities   $ (17.7 )   $ 35.8     Net income including non-controlling interest was $38.3 million in the first three months of 2022 compared to $29.8 million in the first three months of 2021. Depreciation and amortization expense totaled $36.0 million in the first three months of 2022 compared to $35.7 million in the first three months of 2021. Deferred income taxes was a use of cash of $6.0 million in 2022 compared to $2.3 million in the first three months of 2021. Accrued compensation was a use of cash of $44.1 million in 2022 compared to $18.1 million last year. Other assets was a use of cash of $3.2 million in the first three months of 2022 compared to $1.9 million in the first three months of 2021. Other liabilities was a use of cash of $8.8 million in the first three months of 2022 compared to $17.9 million in the first three months of 2021.   Changes in net working capital (trade receivables, inventory and trade payables) accounted for a use of cash of $27.6 million compared to a source of cash of $7.1 million last year. The table below provides the cash flow impact due to changes in the components of net working capital:       Three Months Ended       February 26,     February 27,   ($ in millions)   2022     2021   Trade receivables, net   $ 13.3     $ 3.3   Inventory     (87.4 )     (63.6 ) Trade payables     46.5       67.4   Total cash flow impact   $ (27.6 )   $ 7.1       ● Trade receivables, net – Trade receivables, net was a source of cash of $13.3 million and $3.3 million in the first three months of 2022 and 2021, respectively. The higher source of cash in 2022 compared to 2021 was due to more cash collected on trade receivables in the current year compared to the prior year. The DSO were 65 days at February 26, 2022 and 63 days at February 27, 2021.    32 Table of Contents     ● Inventory – Inventory was a use of cash of $87.4 million and $63.6 million in the first three months of 2022 and 2021, respectively. The higher use of cash in 2022 is due to increasing inventory costs in 2022 compared to 2021. Inventory days on hand were 81 days as of February 26, 2022 and 70 days as of February 27, 2021.     ● Trade payables – Trade payables was a source of cash of $46.5 million and $67.4 million in the first three months of 2022 and 2021, respectively. The lower source of cash in 2022 compared to 2021 reflects higher payments on trade payables in the current year compared to the prior year.   Cash Flows from Investing Activities:       Three Months Ended       February 26,     February 27,   ($ in millions)   2022     2021   Net cash used in investing activities   $ (274.2 )   $ (42.0 )   Purchases of property, plant and equipment were $48.9 million during the first three months of 2022 compared to $35.3 million for the same period of 2021.  This difference reflects the timing of capital projects and expenditures related to growth initiatives.    During the first three months of 2022, we paid cash to acquire TissueSeal for $22.2 million, Fourny for $14.5 million, net of cash acquired and Apollo for $192.6 million, net of cash acquired.    Cash Flows from Financing Activities:       Three Months Ended       February 26,     February 27,   ($ in millions)   2022     2021   Net cash provided by (used in) financing activities   $ 287.8     $ (15.7 )   Borrowings on our revolving credit facility were $307.5 million in the first three months of 2022 to finance acquisitions and for general working capital purposes. We did not make any payments of long-term debt in the first three months of 2022 and payments of long-term debt in the first three months of 2021 were $11.0 million. Net payments of notes payable were $7.6 million in the first three months of 2022 and were flat in the same period of 2021. Cash dividends paid were $8.9 million in the first three months of 2022 compared to $8.5 million in the same period of 2021. Repurchases of common stock were $3.6 million in the first three months of 2022 compared to $2.6 million in the same period of 2021.   Forward-Looking Statements and Risk Factors   The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "intend," "estimate," "will," "should," "could" (including the negative or variations thereof) and other expressions that indicate future events and trends. These plans and expectations are based upon certain underlying assumptions, including those mentioned with the specific statements. Such assumptions are in turn based upon internal estimates and analyses of current market conditions and trends, our plans and strategies, economic conditions and other factors. These plans and expectations and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. In addition to the factors described in this report, Item 1A. Risk Factors identifies some of the important factors that could cause our actual results to differ materially from those in any such forward-looking statements. In order to comply with the terms of the safe harbor, we have identified these important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from the anticipated results or other expectations expressed in the forward-looking statements. These factors should be considered, together with any similar risk factors or other cautionary language that may be made elsewhere in this Quarterly Report on Form 10-Q.   The list of important factors in Item 1A. Risk Factors does not necessarily present the risk factors in order of importance. This disclosure, including that under Forward-Looking Statements and Risk Factors, and other forward-looking statements and related disclosures made by us in this report and elsewhere from time to time, represents our best judgment as of the date the information is given. We do not undertake responsibility for updating any of such information, whether as a result of new information, future events, or otherwise, except as required by law. Investors are advised, however, to consult any further public company disclosures (such as in filings with the SEC or in our press releases) on related subjects.   33 Table of Contents     Item 3. Quantitative and Qualitative Disclosures about Market Risk   We are exposed to various market risks, including changes in interest rates, foreign currency rates and prices of raw materials. Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and foreign currency exchange rates.  See Part II, Item 7A in our Annual Report on Form 10-K for the year ended November 27, 2021 for further discussion of these market risks. There have been no material changes in the reported market risk of the Company since November 27, 2021.    Item 4. Controls and Procedures   Controls and Procedures   We conducted an evaluation, under the supervision and with the participation of our president and chief executive officer and executive vice president, chief financial officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act)) as of February 26, 2022. Based on this evaluation, our president and chief executive officer and executive vice president, chief financial officer concluded that, as of February 26, 2022, our disclosure controls and procedures were effective.   For purposes of Rule 13a-15(e), the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its president and chief executive officer and executive vice president, chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.   Changes in Internal Control over Financial Reporting   There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.   PART II. OTHER INFORMATION   Item 1. Legal Proceedings   Environmental Matters     From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. Also, from time to time, we are identified as a potentially responsible party (“PRP”) under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis.   Currently, we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites.   We are also engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish a financial provision. It is reasonably possible that we may have additional liabilities related to these known environmental matters. However, the full extent of our future liability for environmental matters is difficult to predict because of uncertainty as to the cost of investigation and clean up of the sites, our responsibility for such hazardous substances and the number of and financial condition of other potentially responsible parties.   34 Table of Contents   While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.   Other Legal Proceedings     From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including asbestos-related litigation, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.   For additional information regarding environmental matters and other legal proceedings, see Note 12 to our Consolidated Financial Statements.   Item 1A. Risk Factors   This Form 10-Q contains forward-looking statements concerning our future programs, products, expenses, revenue, liquidity and cash needs as well as our plans and strategies. These forward-looking statements are based on current expectations and we assume no obligation to update this information. Numerous factors could cause actual results to differ significantly from the results described in these forward-looking statements, including the risk factors identified under Part I, Item 1A. Risk Factors contained in our Annual Report on Form 10-K for the fiscal year ended November 27, 2021. There have been no material changes in the risk factors disclosed by us under Part I, Item 1A. Risk Factors contained in the Annual Report on Form 10-K for the fiscal year ended November 27, 2021, except for the addition of the following risk factor:     The military conflict between   Russia   and Ukraine, and the global response to it, could adversely impact our revenues, gross margins and financial results.   The U.S. government and other nations have imposed significant restrictions on most companies’ ability to do business in Russia as a result of the military conflict between Russia and Ukraine. It is not possible to predict the broader or longer-term consequences of this conflict, which could include further sanctions, embargoes, regional instability, geopolitical shifts and adverse effec ts on macroeconomic conditions, security conditions, currency exchange rates and financial markets. Such geo-political instability and uncertainty could have a negative impact on our ability to sell to, ship products to, collect payments from, and support customers in certain regions based on trade restrictions, embargoes and export control law restrictions, and logistics restrictions including closures of air space, and could increase the costs, risks and adverse impacts from these new challenges. We may also be the subject of increased cyber-attacks.  While Russia does not constitute a material portion of our business, a significant escalation or expansion of economic disruption or the conflict's current scope could have a material adverse effect on our results of operations.   35 Table of Contents   Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   Issuer Purchases of Equity Securities   Information on our purchases of equity securities during the first quarter ended February 26, 2022 is as follows:                       (d)                       Maximum                       Approximate Dollar       (a)             Value of Shares that       Total     (b)     may yet be       Number of     Average     Purchased Under the       Shares     Price Paid     Plan or Program   Period   Purchased1     per Share     (millions)                             November 28, 2021 - December 1, 2021     -     $ -     $ 187,170                             December 2, 2021 - January 29, 2022     47,067     $ 56.87     $ 187,170                             January 30, 2022 - February 26, 2022     2,262     $ 71.88     $ 187,170     1 The total number of shares purchased are shares withheld to satisfy the employees’ withholding taxes upon vesting of restricted stock.   Repurchases of common stock are made to support our stock-based employee compensation plans and for other corporate purposes. Upon vesting of restricted stock awarded to employees, shares are withheld to cover the employees’ minimum withholding taxes.   On April 6, 2017, the Board of Directors authorized a new share repurchase program of up to $200.0 million of our outstanding common shares. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduce our common stock for the par value of the shares with the excess being applied against additional paid-in capital. This authorization replaces the September 30, 2010 authorization to repurchase shares.   36 Table of Contents   Item 6. Exhibits     10.1 Increasing Lender Supplement, dated January 24, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, among H.B. Fuller Company, JP Morgan Chase Bank, N.A., as administrative agent, and the lenders party thereto   10.2 Amendment No. 1, dated as of February 28, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, between H.B. Fuller Company and JP Morgan Chase Bank, N.A., as administrative agent   10.3 Increasing Lender Supplement, dated March 4, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, among H.B. Fuller Company, JP Morgan Chase Bank, N.A., as administrative agent, and the lenders party thereto   31.1 Form of 302 Certification – James J. Owens   31.2 Form of 302 Certification – John J. Corkrean   32.1 Form of 906 Certification – James J. Owens   32.2 Form of 906 Certification – John J. Corkrean   101 The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended February 26, 2022 formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Total Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements.   104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).   37 Table of Contents   SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.     H.B. Fuller Company                 Dated: March 24, 2022   /s/ John J. Corkrean       John J. Corkrean       Executive Vice President,       Chief Financial Officer     38 Table of Contents   Exhibit Index   Exhibits     10.1 Increasing Lender Supplement, dated January 24, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, among H.B. Fuller Company, JP Morgan Chase Bank, N.A., as administrative agent, and the lenders party thereto   10.2 Amendment No. 1, dated as of February 28, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, between H.B. Fuller Company and JP Morgan Chase Bank, N.A., as administrative agent   10.3 Increasing Lender Supplement, dated March 4, 2022, to the Amended and Restated Credit Agreement dated October 20, 2020, among H.B. Fuller Company, JP Morgan Chase Bank, N.A., as administrative agent, and the lenders party thereto   31.1 Form of 302 Certification – James J. Owens   31.2 Form of 302 Certification – John J. Corkrean   32.1 Form of 906 Certification – James J. Owens   32.2 Form of 906 Certification – John J. Corkrean   101 The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended February 26, 2022 formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Total Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements.   104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).   39